摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-溴喹喔啉-2-胺 | 181871-83-0

中文名称
5-溴喹喔啉-2-胺
中文别名
5-溴喹唑啉-2-胺
英文名称
2-amino-5-bromoquinazoline
英文别名
5-bromoquinazolin-2-amine
5-溴喹喔啉-2-胺化学式
CAS
181871-83-0
化学式
C8H6BrN3
mdl
——
分子量
224.06
InChiKey
GFCQMFNVELGDHD-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    248-249 °C (decomp)
  • 沸点:
    425.3±37.0 °C(Predicted)
  • 密度:
    1.744±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    12
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    51.8
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2933990090

SDS

SDS:fe366d0c358bee2a1050c03fba4988e1
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 2-Amino-5-bromoquinazoline
Synonyms: 5-Bromoquinazolin-2-amine

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 2-Amino-5-bromoquinazoline
CAS number: 181871-83-0

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H6BrN3
Molecular weight: 224.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

  • 作为反应物:
    描述:
    5-溴喹喔啉-2-胺吡啶(1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloridepotassium acetate 作用下, 以 1,4-二氧六环 为溶剂, 反应 4.0h, 生成 N-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)quinazolin-2-yl)pivalamide
    参考文献:
    名称:
    [EN] GCN2 MODULATOR COMPOUNDS
    [FR] COMPOSÉS MODULATEURS DE GCN2
    摘要:
    本公开涉及式(1)的新化合物或其盐,其中X、Y、R1、R2、R3、R4和R5如本文所定义,并其在治疗、预防、改善、控制或减少与广泛控制不可抑制2(GCN2)相关的疾病风险中的用途。
    公开号:
    WO2021165346A1
  • 作为产物:
    描述:
    2-溴-6-硝基苄溴盐酸硫酸铁粉 作用下, 以 乙二醇乙醚乙醇 为溶剂, 反应 2.51h, 生成 5-溴喹喔啉-2-胺
    参考文献:
    名称:
    Design of Triple Helix Forming C-Glycoside Molecules
    摘要:
    The modeling, synthesis, and characterization of oligomers containing 2-aminoquinazolin-5-yl 2'-deoxynucleotide residues are reported. The 2-arninoquinazoline residues sequence specifically bind via Hoogsteen base pairing as a third strand in the center of the major groove at TA base pair Watson-Crick duplex sequences. Evidence for the formation of a sequence specific three-stranded structure is based on thermal denaturation UV-vis and fluorescence studies. The novel 2-aminoquinazoline C-nucleoticle is a component of a system designed to overcome the homopurine requirement for triple helix structures.
    DOI:
    10.1021/ja028033x
点击查看最新优质反应信息

文献信息

  • ALKYNYL HETEROAROMATIC COMPOUND AND USE THEREOF
    申请人:Nanjing Sanhome Pharmaceutical Co., Ltd.
    公开号:US20150152088A1
    公开(公告)日:2015-06-04
    The present invention belongs to the field of pharmaceutical chemistry, and specifically relates to compounds having an alkynyl heteroaromatic ring structure and pharmaceutically acceptable salts, stereoisomers, N-oxides, solvates, or prodrugs thereof, and pharmaceutical compositions comprising these compounds, as well as uses of these compounds and compositions in the manufacture of a medicament. The compounds of the present invention and the pharmaceutically acceptable salts, stereoisomers, N-oxides, solvates or prodrugs thereof and the pharmaceutical compositions comprising the compounds have better anti-tumor activity.
    本发明属于药物化学领域,具体涉及具有炔基杂芳环结构和药学上可接受的盐、立体异构体、N-氧化物、溶剂合物或前药的化合物,以及包含这些化合物的药物组合物,以及这些化合物和组合物在制备药物中的用途。本发明的化合物和药学上可接受的盐、立体异构体、N-氧化物、溶剂合物或前药以及包含这些化合物的药物组合物具有更好的抗肿瘤活性。
  • ALKYNYL HETEROAROMATIC RING COMPOUND AND APPLICATION THEREOF
    申请人:Nanjing Sanhome Pharmaceutical Co., Ltd.
    公开号:EP2896620A1
    公开(公告)日:2015-07-22
    The present invention belongs to the field of pharmaceutical chemistry, and specifically relates to compounds having an alkynyl heteroaromatic ring structure and pharmaceutically acceptable salts, stereoisomers, N-oxides, solvates, or prodrugs thereof, and pharmaceutical compositions comprising these compounds, as well as uses of these compounds and compositions in the manufacture of a medicament. The compounds of the present invention and the pharmaceutically acceptable salts, stereoisomers, N-oxides, solvates or prodrugs thereof and the pharmaceutical compositions comprising the compounds have better anti-tumor activity.
    本发明属于药物化学领域,具体涉及具有炔杂芳环结构的化合物及其药学上可接受的盐、立体异构体、N-氧化物、溶解物或原药,以及包含这些化合物的药物组合物,以及这些化合物和组合物在制造药物中的用途。本发明的化合物及其药学上可接受的盐、立体异构体、N-氧化物、溶解物或原药以及包含这些化合物的药物组合物具有更好的抗肿瘤活性。
查看更多